{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T05:14:43Z","timestamp":1769577283006,"version":"3.49.0"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>\n                    Neuromuscular genetic disorders (NMGDs) are genetically and clinically diverse group of inherited diseases that affect approximately 1 in 1,000 people worldwide with a calculated prevalence of 37 per 10,000 in the general population. These disorders arise from a variety of genetic changes such as insertions, deletions, duplications and expansions of repeats in more than 747 nuclear and mitochondrial genes critical for the function of peripheral nerves, motor neurons, neuromuscular junctions or skeletal muscles, leading to progressive weakness and degeneration of muscles. Major subtypes include muscular dystrophies, congenital myopathies, motor neuron diseases, peripheral neuropathies, and mitochondrial myopathies. Clinical presentation of NMGDs is highly variable in the age of onset, severity and pattern of muscle involvement, often leading to prolonged and complex diagnostic process. Conventional diagnostic methods have relied on clinical history, physical examination and invasive procedures like muscle biopsy. But the development of next-generation sequencing (NGS) has transformed diagnostics by enabling comprehensive analysis of NMGD-related genes. Despite this advancement, interpreting the numerous variants identified by NGS remains challenging. The guidelines of the American College of Medical Genetics and Genomics (ACMG) offer a standardized approach to variant classification as pathogenic, likely pathogenic, variant of uncertain significance, likely benign and benign. However, this requires the integration of complex evidence from population data, computational predictions, and functional assays. The major challenge is the robust correlation of genotypic information with the huge phenotypic range of NMGDs which is a task complicated by the unavailability of population-specific genetic databases. To address these issues, we have developed NMPhenogen (\n                    <jats:uri>https:\/\/gi-lab-tigs.github.io\/Homepage\/<\/jats:uri>\n                    ), a new database designed to enhance the diagnosis and understanding of NMGDs. NMPhenogen is a centralized repository for data related to NMGD-associated genes and variants along with their clinical presentations. It includes two primary modules: NMPhenoscore, which enhances disease-phenotype correlations, and a Variant classifier, which facilitates standardized variant classification based on published guidelines. This combined resource aims to streamline the diagnostic process, support clinical decision-making, and eventually contribute to improving patient care and genetic counseling.\n                  <\/jats:p>","DOI":"10.3389\/fnins.2025.1696899","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T06:10:40Z","timestamp":1762236640000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["NMPhenogen: a comprehensive database for genotype\u2013phenotype correlation in neuromuscular genetic disorders"],"prefix":"10.3389","volume":"19","author":[{"given":"Usha","family":"Manjunath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkatesh","family":"R","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sacheta Sudhendra","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harshatha N.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anupama","family":"Anil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh Kumar","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gayatri Rangarajan","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/S13311-018-00674-4","article-title":"Diagnosis and treatment of mitochondrial myopathies","volume":"15","author":"Ahmed","year":"2018","journal-title":"Neurotherapeutics"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"192","DOI":"10.11251\/ojjscn.50.192","article-title":"Genetic testing for neuromuscular disorders","volume":"50","author":"Arakawa","year":"2018","journal-title":"No To Hattatsu"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"5835","DOI":"10.1007\/s12035-019-1478-5","article-title":"NeuroMuscleDB: a database of genes associated with muscle development, neuromuscular diseases, ageing, and neurodegeneration","volume":"56","author":"Baig","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"105261","DOI":"10.1016\/J.NMD.2024.105261","article-title":"The 2025 version of the gene table of neuromuscular disorders (nuclear genome)","volume":"46","author":"Benarroch","year":"2025","journal-title":"Neuromuscul. Disord."},{"key":"ref5","author":"Bird","year":"2019"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e00304","DOI":"10.1016\/j.neurot.2023.11.001","article-title":"A clinical approach to diagnosis and management of mitochondrial myopathies","volume":"21","author":"Chin","year":"2024","journal-title":"Neurotherapeutics"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.33590\/emjneurol\/10313878","article-title":"Diagnosing neuromuscular diseases","volume":"2018","author":"Dubrovsky","year":"2018","journal-title":"EMJ Neurol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s00415-011-6062-5","article-title":"A systematic review of quality of life in adults with muscle disease","volume":"258","author":"Graham","year":"2011","journal-title":"J. Neurol."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"533","DOI":"10.4103\/aian.AIAN_32_19","article-title":"Prevalence of epilepsy and its association with exposure to toxocara canis: a community-based, case-control study from Rural Northern India","volume":"22","author":"Kashyap","year":"2019","journal-title":"Ann. Indian Acad. Neurol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3109\/10408363.2012.658906","article-title":"Genetics of neuromuscular disorders","volume":"49","author":"Laing","year":"2012","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s12038-023-00403-w","article-title":"Rare paediatric disorders in Indian healthcare settings with focus on neuromuscular disorders: diagnostic and management challenges","volume":"49","author":"Mahesan","year":"2024","journal-title":"J. Biosci."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.neurol.2016.08.004","article-title":"Nemaline myopathies: state of the art","volume":"172","author":"Malfatti","year":"2016","journal-title":"Rev. Neurol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s13023-025-03742-z","article-title":"The most bothersome symptoms in neuromuscular diseases: the ERN EURO NMD survey","volume":"20","author":"Mancuso","year":"2025","journal-title":"Orphanet J. Rare Dis."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1016\/j.otsr.2017.04.019","article-title":"Neuromuscular diseases: diagnosis and management","volume":"104","author":"Mary","year":"2018","journal-title":"Orthop. Traumatol. Surg. Res."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.pmr.2012.06.011","article-title":"Clinical approach to the diagnostic evaluation of herditary","volume":"23","author":"Mcdonald","year":"2012","journal-title":"Phys. Med. Rehabil. Clin. N. Am."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-06547-3","article-title":"A machine learning approach based on ACMG\/AMP guidelines for genomic variant classification and prioritization","volume":"12","author":"Nicora","year":"2022","journal-title":"Sci. Rep."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/GIM.0b013e31816b5cae","article-title":"ACMG recommendations for standards for interpretation and reporting of sequence variations: revisions 2007","volume":"10","author":"Richards","year":"2008","journal-title":"Genet. Med."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1002\/ajmg.a.63356","article-title":"An evaluation of clinical presentation and genetic testing approaches for patients with neuromuscular disorders","volume":"191","author":"Rosenberg","year":"2023","journal-title":"Am. J. Med. Genet. A"},{"key":"ref20","first-page":"55","article-title":"Clinical scales for the evaluation of neuromuscular patients","volume-title":"Muscular dystrophy: causes and management","author":"Semplicini","year":"2013"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s44162-025-00088-9","article-title":"Centre-based landscape of muscular dystrophies in Gujarat: insight into genetic diagnosis and management","volume":"4","author":"Sindhav","year":"2025","journal-title":"J. Rare Dis."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/ajmg.a.20409","article-title":"Contribution of malformations and genetic disorders to mortality in a children\u2019s hospital","author":"Stevenson","year":"2004","journal-title":"Am. J. Med. Genet."},{"key":"ref23","volume-title":"The three component individualism scale (English Version) 0.2","author":"Version","year":"2002"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1590\/1678-4685-gmb-2016-0019","article-title":"Genetics in neuromuscular disorders","volume":"348","author":"Zatz","year":"2016","journal-title":"Crit. Rev. Clin. Lab. Sci."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2025.1696899\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T06:10:41Z","timestamp":1762236641000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2025.1696899\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":24,"alternative-id":["10.3389\/fnins.2025.1696899"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2025.1696899","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"article-number":"1696899"}}